If you had your choice, for initial treatment in low risk CLL, which would you choose Ibrutinib, Acalabrutinib, or Zanubrutinib ?
I ask because, some health care organizations are offering a change from ibrutinib to their patients. In addition to starting new patients on Zanubrutinib , when choosing/initiating BTK inhibitors.